Return
Response to: Commentary on “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study”
A
A
I
J
R
D
Y
L
Y
R
A
C
A
W
DOI:10.1016/j.euroneuro.2026.112885.png)
Abstract
En
Journal
IF:
6.7
Papers:
2.4W
Citations:
8.7K

